Dual Injection ESPB Versus Single Injection ESPB for Laparotomies
NCT ID: NCT05633329
Last Updated: 2023-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-12-07
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Ultrasound Guided Erector Spinae Plane Block
NCT04371705
Ultrasound-guided Erector Spinae Block Versus Quadratus Lumborum Block for Laparotomies
NCT04965194
Comparison of Ultrasound-Guided Bilateral Erector Spinae Plane Block Versus Bilateral Rectus Sheath Block in Adults Undergoing Major Abdominal Surgery
NCT04229420
Ultrasound Guided Erector Spinae Plane Block Versus Retrolaminar Plane Block
NCT05705739
Erector Spinae Block Versus Local Field Block in Lumbar Spine Surgeries
NCT05570565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single ESPB
single injection at level T8
single level
injection of 40 ml bupivacaine 0.25 at T8 (20 ml on each side)
dual ESB
dual injection at level T7 and T9
dual level
injection of 40 ml of bupivacaine 0.25 at two level T7 and T9 (10 ml on each level of both side)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
single level
injection of 40 ml bupivacaine 0.25 at T8 (20 ml on each side)
dual level
injection of 40 ml of bupivacaine 0.25 at two level T7 and T9 (10 ml on each level of both side)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Both genders.
3. abdominal surgery.
4. ASA I-III.
Exclusion Criteria
2. Morbid obesity (BMI \>40 kg/m2).
3. Psychiatric disorder.
4. Opiod dependence.
5. patient refuse.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hassan Mokhtar Elshorbagy Hetta
lecturer of anesthesia and ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hassan m. hetta, lecturer
Role: PRINCIPAL_INVESTIGATOR
Minia University, faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia University
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
474:10/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.